![Norman Eansor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 800 $ al 31/05/2026
Norman David Eansor is currently Chairman at Marker Therapeutics, Inc. since 2022, Director at B-MoGen Biotechnologies, Inc., and President at Cyvek, Inc. Former positions include President-Bioproducts Business Unit at Cambrex Corp.
in 2005, President-Protein Sciences Segment at Bio-Techne Corp.
from 2018 to 2022, Vice President-Pharmaceutical Operations at R.P.
Scherer Corp., President-Bioscience Division at Thermo Fisher Scientific, Inc. from 2010 to 2013, Vice President-Operations at Cardinal Health Corp.
in 2000, and Senior Vice President-Development & MD at Novus Biologicals LLC from 2013 to 2015.
Education includes undergraduate studies at the University of Western Ontario and an MBA from the University of Windsor.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 01/03/2026 | 3.694 ( 0,02 % ) | 5 800 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| MARKER THERAPEUTICS, INC. | Presidente | 24/05/2022 |
B-MoGen Biotechnologies, Inc.
 B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Director/Miembro de la Junta | - |
CyVek, Inc.
 CyVek, Inc. BiotechnologyHealth Technology Engages in the development of a novel, platform technology for measuring analytes in biological samples | Presidente | - |
| Empresas | Cargo | Fin |
|---|---|---|
| BIO-TECHNE CORPORATION | Corporate Officer/Principal | 03/01/2022 |
Novus Biologicals LLC
 Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Develops and markets antibodies for scientific researchers | Corporate Officer/Principal | 01/01/2015 |
| THERMO FISHER SCIENTIFIC, INC. | Corporate Officer/Principal | 01/01/2013 |
| CAMBREX CORPORATION | Corporate Officer/Principal | 01/01/2005 |
Cardinal Health Corp.
 Cardinal Health Corp. Medical DistributorsDistribution Services Manufactures and distributes hospital equipment | Director de Operaciones | 01/01/2000 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 11 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Develops and manufactures drug substances | Health Technology |
R.P. Scherer Corp.
 R.P. Scherer Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures oral drug delivery systems | Health Technology |
Bio-Techne Corp.
 Bio-Techne Corp. BiotechnologyHealth Technology Manufactures and sells biological products | Health Technology |
Marker Therapeutics, Inc.
 Marker Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes cell based immune therapeutics and vaccines for cancer treatment | Health Technology |
CyVek, Inc.
CyVek, Inc. BiotechnologyHealth Technology Engages in the development of a novel, platform technology for measuring analytes in biological samples | Health Technology |
University of Western Ontario
 University of Western Ontario Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Windsor
 University of Windsor Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thermo Fisher Scientific, Inc.
 Thermo Fisher Scientific, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and markets analytical and environment monitoring instruments | Health Technology |
Novus Biologicals LLC
Novus Biologicals LLC Pharmaceuticals: MajorHealth Technology Develops and markets antibodies for scientific researchers | Health Technology |
Cardinal Health Corp.
Cardinal Health Corp. Medical DistributorsDistribution Services Manufactures and distributes hospital equipment | Distribution Services |
B-MoGen Biotechnologies, Inc.
B-MoGen Biotechnologies, Inc. BiotechnologyHealth Technology Provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
